Johnson & Johnson Acknowledges EP Market Competition, Expects China's VBP to Impact Market
Johnson & Johnson (JNJ) MedTech Chairman Tim Schmid acknowledged competitive pressure in the electrophysiology (EP) market, particularly in international and Asia-Pacific markets including China. He anticipates China's volume-based procurement (VBP) program will eventually affect the EP market, potentially later this year and into 2027, and plans to add one meaningful pulsed field ablation (PFA) catheter annually for the next three to five years.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.
24H Trending
-
1
stated at the 35th annual CASPA conference held in the US on October 23rd that AI infrastructure investment is facing multiple challenges
-
2
UAE's oil supply rebounded to a record high of 5.3 million barrels per day (bpd) in September
-
3
Mishaboar posted on X, proposing several measures for the growth of the Dogecoin ecosystem
-
4
TREAT Token: An Analysis of the Core Token in the Shiba Inu Ecosystem
-
5
Sri Lanka's real estate market is experiencing a luxury property boom
-
6
Bulgarians are voting in a presidential election today
-
7
Mainstream Cryptocurrency Exchanges and Essential Analysis Tools
-
8
What is HOLD (Interstellar Holdings)? Project Details and Risk Analysis
-
9
Deutsche Bank noted that the correction in U.S. tech stocks may not be over yet
-
10
Which Platforms Allow Trading of Virtual Currencies Now? An Analysis of the Top 10 Mainstream Virtual Currency Trading Platforms
Markets Today
Recommended Reading





